References
- Shapiro AK, Shapiro ES, Young JG, et al. Gilles de la Tourette syndrome. 2d ed. New York: Raven Press, 1988
- Comings DE, Comings BG. Tourette's syndrome and attention deficit disorder. In: Cohen DJ, Bruun RD, Leckman JF, eds. Tourette's syndrome and tic disorders: clinical understanding and treatment. New York: J Wiley, 1988: 119–35
- Robertson MM. The Gilles de la Tourette syndrome: the current status. Br J Psychiatry 1989: 154: 147–69
- Kurlan R. Tourette's syndrome: current concepts. Neurology 1989: 39(12): 1625–30
- Singer HS, Walkup JT. Tourette syndrome and other tic disorders: diagnosis, pathophysiology, and treatment. Medicine (Baltimore) 1991: 70(1): 15–32
- Lowe TL, Cohen DJ, Detlor J, et al. Stimulant medications precipitate Tourette's syndrome. JAMA 1982: 247(8): 1168–9
- Kurlan R, Lichter D, Hewitt D. Sensory tics in Tourette's syndrome. Neurology 1989: 39(5): 731–4
- Singh SK, Jankovic J. Tardive dystonia in patients with Tourette's syndrome. Mov Disord 1988: 3(3): 274–80
- Shapiro AK, Shapiro E, Fulop G. Pimozide treatment of tic and Tourette disorders. Pediatrics 1987: 79(6): 1032–9
- Regeur L, Pakkenberg B, Fog R, et al. Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome. J Neurol Neurosurg Psychiatry 1986: 49(7): 791–5
- Walsh TL, Lavenstein B, Licamele WL, et al. Calcium antagonists in the treatment of Tourette's disorder. Am J Psychiatry 1986: 143(11): 1467–8
- Goetz CG, Tanner CM, Wilson RS, et al. Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods. Ann Neurol 1987: 21(3): 307–10
- Leckman JF, Ort S, Caruso KA, et al. Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine: behavioral, cardiovascular, and neurochemical effects. Arch Gen Psychiatry 1986: 43(12): 1168–76
- Pauls DL, Towbin KE, Leckman JF, et al. Gilles de la Tourette's syndrome and obsessive-compulsive disorder: evidence supporting a genetic relationship. Arch Gen Psychiatry 1986: 43(12): 1180–2
- Flament MF, Rapoport JL, Berg CJ, et al. Clomipramine treatment of childhood obsessive-compulsive disorder: a double-blind controlled study. Arch Gen Psychiatry 1985: 42(10): 977–83
- Riddle MA, Hardin MT, King R, et al. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1990: 29(1): 45–8
- Como PG, Kurlan R. An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome. Neurology 1991: 41(6): 872–4
- Comings DE, Comings BG. Tourette's syndrome and attention deficit disorder. In: Cohen et al, eds,2 pp 119–35
- Riddle MA, Hardin MT, Cho SC, et al. Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1988: 27(6): 811–4
- Kurlan R, Majumdar L, Deeley C, et al. A controlled trial of propoxyphene and naltrexone in patients with Tourette's syndrome. Ann Neurol 1991: 30(1): 19–23